Showing results (11-20 of 124) with videos related to
Sort By:
Pageof 13
Expert Review of Clinical Pharmacology|March 7, 2012
Mesalamine in the treatment and maintenance of remission of ulcerative colitisMaggie Ham, Alan C MossClinical and Experimental Gastroenterology|June 23, 2011
Cause for controversy? Infliximab in the treatment of ulcerative colitis: an updateGarrett Lawlor, Alan C MossClinical Pharmacology : Advances and Applications|August 14, 2012
Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX(®) mesalamineKavinderjit Nanda, Alan C MossSouthern Medical Journal|April 3, 2007
Reflux, dyspepsia, and disorders of the foregutAlan C Moss, Ciarán P KellyFrontiers in Pharmacology|June 28, 2021
Exosomes in Intestinal InflammationKanchana K Ayyar, Alan C MossFrontline Gastroenterology|July 12, 2021
Implications of recurrent SARS-CoV-2 outbreaks for IBD managementJonathan P Segal, Alan C MossInflammatory Bowel Diseases|December 10, 2009
Ocular manifestations in a community-based cohort of patients with inflammatory bowel diseaseDídia Bismara Cury, Alan C MossClinical Investigation|February 18, 2014
Novel treatment options for ulcerative colitisByron P Vaughn, Alan C MossDrugs|June 13, 2008
Steroid-refractory severe ulcerative colitis: what are the available treatment options?Alan C Moss, Mark A PeppercornExpert Review of Gastroenterology & Hepatology|December 17, 2008
Balsalazide disodium for the treatment of ulcerative colitisSeema A Patil, Alan C MossPageof 13